Crossmark Global Holdings Inc. Sells 105 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Crossmark Global Holdings Inc. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 1.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,075 shares of the medical device company’s stock after selling 105 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Cooper Companies were worth $1,001,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of the company. Vanguard Group Inc. increased its stake in Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after acquiring an additional 17,367,502 shares during the last quarter. Capital World Investors raised its holdings in Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after buying an additional 4,246,519 shares during the period. Janus Henderson Group PLC lifted its position in Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after buying an additional 2,532,186 shares during the last quarter. Bessemer Group Inc. boosted its stake in Cooper Companies by 305.2% during the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after buying an additional 1,507,049 shares during the period. Finally, Swedbank AB bought a new position in Cooper Companies during the first quarter valued at $139,246,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The trade was a 24.94 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Daniel G. Mcbride sold 114,992 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This trade represents a 72.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock worth $27,637,427 in the last three months. 2.00% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Morgan Stanley raised their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Wells Fargo & Company boosted their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. StockNews.com upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Down 2.0 %

Shares of Cooper Companies stock opened at $99.86 on Friday. The Cooper Companies, Inc. has a 1 year low of $82.21 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The stock has a market cap of $19.89 billion, a price-to-earnings ratio of 55.48, a PEG ratio of 2.20 and a beta of 0.99. The firm’s 50-day moving average is $106.97 and its two-hundred day moving average is $97.87.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies’s revenue was up 7.8% compared to the same quarter last year. During the same period last year, the company posted $0.84 earnings per share. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.